Altimmune Total Liabilities 2011-2026 | ALT

Annual Total Liabilities Altimmune

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
55 M	15.8 M	16.5 M	21.6 M	19.7 M	19.2 M	8.54 M	6.44 M	14.4 M	205 M	3.21 M	3.7 M	9.8 M	11.1 M	6.95 M	15 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
205 M	3.21 M	27 M

Quarterly Total Liabilities Altimmune

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
51.6 M	32.8 M	29 M	15.1 M	15.8 M	14.5 M	20.8 M	-	16.5 M	16.2 M	15.6 M	19.4 M	21.6 M	20.2 M	15.4 M	20.8 M	19.7 M	27.6 M	16 M	17.8 M	19.2 M	19.2 M	19.2 M	19.2 M	8.54 M	8.54 M	8.54 M	8.54 M	6.44 M	6.44 M	6.44 M	6.44 M	14.4 M	14.4 M	14.4 M	14.4 M	6.19 M	6.19 M	6.19 M	205 M	3.21 M	3.21 M	3.21 M	3.21 M	3.7 M	3.7 M	3.7 M	3.7 M	9.8 M	9.8 M	9.8 M	9.8 M	11.1 M	11.1 M	11.1 M	11.1 M	6.95 M	6.95 M	6.95 M	6.95 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
205 M	3.21 M	16.3 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	6.06 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.56 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	123 M	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
BioNTech SE BNTX	2.76 B	$ 89.59	-	$ 21.7 B	Germany
Compugen Ltd. CGEN	18.5 M	$ 2.22	-	$ 207 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Coherus BioSciences CHRS	197 M	$ 1.58	-	$ 185 M	USA
Athira Pharma ATHA	64.4 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	71.5 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	330 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	645 K	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	6.77 M	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	104 M	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	35.1 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	84 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	55.8 M	$ 29.93	-	$ 1.99 B	USA
Generation Bio Co. GBIO	145 M	-	-	$ 344 M	USA
IMV IMV	38 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Enlivex Therapeutics Ltd. ENLV	392 M	$ 0.79	-	$ 36.1 M	Israel
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
Esperion Therapeutics ESPR	768 M	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	66 M	$ 28.9	-	$ 778 M	USA
Cyclacel Pharmaceuticals CYCCP	1.34 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	34.2 M	-	-	$ 384 M	Britain
Forte Biosciences FBRX	21.8 M	$ 16.69	-	$ 216 M	USA
Gracell Biotechnologies GRCL	281 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	42.3 M	$ 14.79	-	$ 212 M	USA
Advaxis ADXS	2.3 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	17.6 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 3.16	-	$ 5.2 M	Israel
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
CRISPR Therapeutics AG CRSP	343 M	$ 56.95	-	$ 5.12 B	Schweiz
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Galectin Therapeutics GALT	146 M	$ 2.38	-	$ 152 M	USA